$236.55
1.68% today
NYSE, Apr 02, 09:14 pm CET
ISIN
US50540R4092
Symbol
LH

Laboratory Stock price

$232.65
-21.39 8.42% 1M
+13.45 6.14% 6M
+3.33 1.45% YTD
+16.30 7.53% 1Y
+6.57 2.91% 3Y
+132.85 133.12% 5Y
+124.51 115.14% 10Y
NYSE, Closing price Tue, Apr 01 2025
-0.09 0.04%
ISIN
US50540R4092
Symbol
LH
Sector

Key metrics

Market capitalization $19.47b
Enterprise Value $25.24b
P/E (TTM) P/E ratio 26.33
EV/FCF (TTM) EV/FCF 23.03
EV/Sales (TTM) EV/Sales 1.94
P/S ratio (TTM) P/S ratio 1.50
P/B ratio (TTM) P/B ratio 2.41
Dividend yield 1.24%
Last dividend (FY24) $2.88
Revenue growth (TTM) Revenue growth 0.83%
Revenue (TTM) Revenue $13.01b
EBIT (operating result TTM) EBIT $1.14b
Free Cash Flow (TTM) Free Cash Flow $1.10b
Cash position $1.52b
EPS (TTM) EPS $8.84
P/E forward 18.61
P/S forward 1.40
EV/Sales forward 1.81
Short interest 3.03%
Show more

Is Laboratory a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Laboratory Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Laboratory forecast:

16x Buy
73%
6x Hold
27%

Analyst Opinions

22 Analysts have issued a Laboratory forecast:

Buy
73%
Hold
27%

Financial data from Laboratory

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
13,009 13,009
1% 1%
100%
- Direct Costs 9,641 9,641
0% 0%
74%
3,368 3,368
4% 4%
26%
- Selling and Administrative Expenses 1,587 1,587
13% 13%
12%
- Research and Development Expense - -
-
-
1,782 1,782
3% 3%
14%
- Depreciation and Amortization 644 644
9% 9%
5%
EBIT (Operating Income) EBIT 1,138 1,138
0% 0%
9%
Net Profit 746 746
78% 78%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Laboratory directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Laboratory Stock News

Neutral
PRNewsWire
about 9 hours ago
Labcorp's pTau-217/Beta Amyloid 42 Ratio blood test meets the performance criteria to confirm amyloid pathology consistent with Alzheimer's disease BURLINGTON, N.C. , April 2, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide launch of its pTau-217/Beta Amyloid 42 Ratio, a powerful new blood-based biomark...
Neutral
PRNewsWire
one day ago
New offering expands screening options for cervical cancer and sexually transmitted infections (STIs), including chlamydia, gonorrhea, trichomonas or mycoplasma genitalium (Mgen) BURLINGTON, N.C. , April 1, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer nationwide a U.S. Food and Drug Administration (FD...
Neutral
PRNewsWire
2 days ago
BURLINGTON, N.C. , March 31, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2025 before the market opens on Tuesday, April 29, 2025.
More Laboratory News

Company Profile

Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Head office United States
CEO Adam Schechter
Employees 70,000
Founded 1971
Website www.labcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today